Pharmaceutical firms and biotechnology companies have little incentive to develop vaccines for these diseases , because there is little revenue potential , the financial and other risks are great . Pharmaceutical firms and biotechnology companies have little incentive to develop vaccines for these diseases , because there is little revenue potential .